MONKEYPOX
Clinical trials for MONKEYPOX explained in plain language.
Never miss a new study
Get alerted when new MONKEYPOX trials appear
Sign up with your email to follow new studies for MONKEYPOX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New monkeypox vaccine enters human testing
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial is testing a new vaccine against monkeypox in 120 healthy adults aged 18 and older. Participants will receive two doses of either a low or high dose of the MVA strain live vaccine, or a placebo. The study aims to check if the vaccine is safe and whether it …
Matched conditions: MONKEYPOX
Phase: PHASE1 • Sponsor: Shanghai Institute Of Biological Products • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:53 UTC
-
Monkeypox vaccine immune response under the microscope
Knowledge-focused Recruiting nowThis study looks at how the monkeypox vaccine (MVA-BN) sparks immune responses in 100 adults at high risk of infection, including those with and without HIV. Researchers will measure antibodies and other immune markers in blood samples taken after vaccination. The goal is to unde…
Matched conditions: MONKEYPOX
Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Knowledge-focused
Last updated Jul 02, 2026 02:00 UTC
-
Mpox survivors tracked for 5 years to uncover hidden health effects
Knowledge-focused Recruiting nowThis study follows 345 people who had mpox or received the smallpox vaccine to see if there are any long-term physical or mental health problems. Researchers will also check how long the body's immune memory lasts by testing blood, saliva, semen, and anal swabs over 5 years. Part…
Matched conditions: MONKEYPOX
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New poxvirus drug candidate tested in healthy people
Knowledge-focused Recruiting nowThis early-stage study tests the safety and how the body processes a new drug called BSY001 in 76 healthy adults aged 18 to 50. Participants receive either the drug or a placebo, and researchers monitor side effects and drug levels in the blood. The goal is to gather safety infor…
Matched conditions: MONKEYPOX
Phase: PHASE1 • Sponsor: China National Biotec Group Company Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC